Results 251 to 260 of about 80,027 (384)

Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan

, 2000
Ernesto L. Schiffrin, Jeong Bae Park, Hope D. Intengan, Rhian M. Touyz   +3 more
openalex   +1 more source

Advantage of angiotensin-ii receptor antagonists over calcium channel blockers in experimental chronic renal failure-prevention of mesangial hypertrophy in glomeruli [PDF]

, 2000
H. E. Eliahou
openalex   +1 more source

Atrial fibrillation development in the heart failure population from nationwide British linked electronic health records

ESC Heart Failure, EarlyView.
Abstract Aims Atrial fibrillation (AF) is a frequent comorbidity in heart failure (HF). We analysed factors associated with new‐onset atrial fibrillation in patients with heart failure using linked real‐world UK data from primary and secondary care, along with findings from genome‐wide association studies. Methods and results Among 163 174 participants
Hiroyuki Yoshimura, Nikhil Paliwal, Arturo Gonzalez‐Izquierdo, Chris Finan, Amand Floriaan Schmidt, Gregory Y.H. Lip, Rui Providencia   +6 more
wiley   +1 more source

The Changing Landscape of Heart Failure Drug Clinical Trials in China, 2013-2023. [PDF]

Drug Des Devel Ther
Zhang W, Zhang Y, Tang J, Wang X, Meng C, Wu J, Li J.   +6 more
europepmc   +1 more source

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes

, 2000
Craig Cheetham, Julie Collis, G. O’Driscoll, K. Stanton, Roger R. Taylor, Daniel J. Green   +5 more
openalex   +1 more source

The ventricular-arterial coupling after angiotensin II receptor antagonist therapy is not renin-dependent [PDF]

, 2000
Gregory P. Vyssoulis, E. Karpanou, M. Toutouza, D COKKINOS, P. Toutouzas   +4 more
openalex   +1 more source

Survival after myocardial infarction according to left ventricular function and heart failure symptoms

ESC Heart Failure, EarlyView.
Asymptomatic reduced left ventricular ejection fraction (LVEF) in the acute phase of myocardial infarction (AMI) was associated with up to 20% 1‐year mortality after discharge, substantially higher than in recent post‐MI trials. Symptoms of heart failure (HF) during the index hospitalization was associated with worse outcomes in patients with preserved
Jarle Jortveit, Peder L. Myhre, Kristian Berge, Sigrun Halvorsen   +3 more
wiley   +1 more source

Critical Review of the Benefit from Early Pharmacological and Dietary Support for Patients with Moderate-to-Severe (Non-Terminal) Chronic Kidney Disease. [PDF]

Biomedicines
Danneel C, Sauvage C, Hayef MN, Desmet V, Surquin M, Nortier J, De Vriese C.   +6 more
europepmc   +1 more source

A multicentre registry of hospitalized patients with acute and chronic heart failure: Study design of the H2‐registry

ESC Heart Failure, EarlyView.
The H2‐Registry: overview, first results and outlook. Abstract Aims Heart failure (HF) is a highly prevalent condition affecting 1–3% of the adult population in Europe. Despite landmark improvements in HF care over the last two decades, hospitalization and mortality rates remain relatively high.
Johannes Leiner, Sebastian König, Anne Nitsche, Sven Hohenstein, Jana Nagel, Melchior Seyfarth, Henning Baberg, Alexander Lauten, Hans Neuser, Alexander Staudt, Jürgen Tebbenjohanns, René Andrié, Michael Niehaus, Markus W. Ferrari, Ralf Kuhlen, Andreas Bollmann   +15 more
wiley   +1 more source

Novel Versus Conventional Sequencing of β-Blockers, Sodium/Glucose Cotransportor 2 Inhibitors, Angiotensin Receptor-Neprilysin Inhibitors, and Mineralocorticoid Receptor Antagonists in Stable Patients With Heart Failure With Reduced Ejection Fraction (NovCon Sequencing Study): Protocol for a Randomized Controlled Trial.

JMIR Res Protoc
Karamchand S, Chipamaunga T, Naidoo P, Naidoo K, Rambiritch V, Ho K, Chilton R, McMahon K, Leisegang R, Weich H, Hassan K.   +10 more
europepmc   +1 more source